PF-Atlas › Clinical Trials › NCT05988463
Dose-Escalation Study of Artesunate Patients With IPF
Artesuante · Phase 1
Registry ID
NCT05988463
Phase
Phase 1
Status
Recruiting
Drug / intervention
Artesuante
Sponsor
Joseph C. Wu
Start
2026-08-01
About this trial
Artesuante is evaluated in NCT05988463, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Joseph C. Wu. Current status: Recruiting.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT05988463 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.